On September 15, Immunize Colorado hosted two of Colorado’s top immunization experts for a town-hall style panel discussion of the latest updates on the COVID-19 pandemic and vaccination. Panelists Dr. Sean O’Leary, Pediatric Infectious Diseases Specialist at Children’s Hospital Colorado, and Heather Roth, Immunization Branch Chief at the Colorado Department of Public Health and Environment (CDPHE), answered audience questions about COVID-19 variants, COVID-19 vaccines (including potential booster doses and availability for young children), and the status of routine vaccination in Colorado.
By Amy Bell
The COVID-19 pandemic has highlighted the importance of rapid health communications, especially as protocols change quickly as new information unfolds. During the pandemic, this has proved especially challenging for public health in keeping non-English speakers up to date with the latest information.
Dr. Lisa Diamond recently published a paper titled, “Providing Equitable Care to Patients with Limited Dominant Language Proficiency Amid the COVID-19 Pandemic.” Dr. Diamond writes, “We know from years of research that patients with Limited English Proficiency experience disparities in timely receipt of public health messaging, understanding of important health information, and access to insurance and health care.”
As an AmeriCorps VISTA serving at Immunize Colorado in Aurora, Colorado, I wanted to create a project that addressed these language barriers and helped get these communities access to the COVID-19 Vaccine.
Since the first COVID-19 vaccines became available, healthcare professionals, community workers, and politicians alike have been urging anyone eligible for a vaccine to get one. With cases still circulating in the U.S. and new variants threatening to worsen conditions, mass vaccination appears to be the best way out of the pandemic.
There are currently three COVID-19 vaccines Moderna, Pfizer, and Johnson & Johnson (J&J), approved through Emergency Use Authorization (EUA) in the United States. So far, over 2.3 million total vaccines have been administered in the country as of April 27, 2021.The most recently approved vaccine, the Johnson & Johnson (Janssen) vaccine, was approved on February 27th, 2021, for all adults (18+).
Guest Post by Angie Anderson
A year ago, no one could have imagined how different the world would be today. Pandemic life is hard: lock downs, capacity restrictions, masks, school shutdowns and online learning, and the worst part—climbing death counts. With a husband who works in the COVID-19 unit of the ICU, I realize how debilitating and potentially deadly a severe case of COVID-19 can be. I don’t want to get this virus and I don’t want to contribute to community spread either. For all these reasons, my family is anxiously awaiting a safe and effective vaccine, which is why I jumped at the chance to participate in a vaccine trial. Read more